Clinical Trials
Introductory exposition (textbooks, tutorial papers, etc.) pertaining to statistics (62-01) Research exposition (monographs, survey articles) pertaining to statistics (62-02) Optimal statistical designs (62K05) Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50)
This book's purpose is the access to the methodology of clinical trials for interested statistical and clinical scientists by a total of 22 chapters and 8 appendices, 49 pages of references and another 30 pages of author index and subject index. So it attempts to acquaint investigators with ideas of design methodology that are helpful in planning, conducting, analyzing and assessing clinical trials. Same as the first edition, this book addresses besides biostatistics students primarily trialists and clinical investigators, who want to learn about good methodology, especially, working toward a degree in clinical investigations with a need for understanding good clinical research methodology. As a text book to be used in classes (one or two quarter second postgraduate courses), workshops and training programs it covers all basic elements of clinical trials and the state of the art of the methodology. The chapters 2--4 on Clinical Trials as Research, Why Clinical Trials are Ethical, and Contexts for Clinical Trials, set up the general context and aspects of clinical trials. The interface to statistics is covered in chapters 5--8 including topics on Clinical Trials as Experimental Designs, Random Error and Bias, and Objectives and Outcomes. Typical biostatistical themes are considered in chapters on Sample Size and Power (2), Treatment Effects Monitoring (14), Estimating Clinical Effects (16), Prognostic Factor Analysis (17), Factorial Designs (19) and Cross-Over Trials (20). Important to mention are the chapters on Reporting and Authorship (18) and Misconduct and Fraud in Clinical Research (22). Other topics are The Study Cohort (12), Treatment Allocation (13), Counting Subjects and Events (15), and Meta Analyses (21). The second edition greatly expands its coverage, ranging from statistical principles to controversial topics, including alternative medicine and ethics and completely new chapters, including: Contexts for Clinical Trials (Chapter 4), Statistical Perspectives (Chapter 5), Translational Clinical Trials (Chapter 9), and Dose-Finding Designs (Chapter 10). Each chapter is accompanied by a summary and discussion questions stimulate critical thinking. Examples from the clinical trials literatlire are used. A review of essential notation and terminology is also provided. This is not a book on statistical theory for clinical trials but on the practical aspects and on the statistical principles behind technicalities. The book leaves terminology out and does not stick to a rigid concept as, e.g., Phase I-IV, prospective-retrospective, etc., but tries to `present concepts that unify all designed studies'. A working knowledge of basic biostatistics and familiarity with clinical trials is required.
- Clinical trials. A methodologic perspective
- Introduction to statistical methods for clinical trials.
- Design and Analysis of Clinical Trials
- Introduction to Randomized Controlled Clinical Trials
- Methods and applications of statistics in clinical trials. Volume 2. Planning, analysis, and inferential methods
- Randomized group up and down experiments
- Biostatistics and clinical trials: A view
- Choice as an alternative to control in observational studies. (With comments and a rejoinder).
- Statistical analysis of survival and reliability data with multiple crossings of survival functions
- Is the FDA too conservative or too aggressive?: a Bayesian decision analysis of clinical trial design
- Building an identifiable latent class model with covariate effects on underlying and measured variables
- Methodology of clinical trials. Methodologic foundations of planning, execution and evaluation.
- Estimating incidence rate on current status data with application to a phase IV cancer trial
- Statistics applied to clinical trials. With the help from Toine F. Cleophas, Eugene P. Cleophas, and Henny I. Cleophas-Allers.
- A new semiparametric estimation method for accelerated hazard model
- Accelerated hazards regression model and its adequacy for censored survival data
- Methodology of clinical trials. Methodologic foundations of planning, execution and evaluation
- Designs for Single- or Multiple-Agent Phase I Trials
- Some topics of current interest in clinical trials
- scientific article; zbMATH DE number 1209380 (Why is no real title available?)
- GROUP SEQUENTIAL TESTS WITH OUTCOME-DEPENDENT TREATMENT ASSIGNMENT
- scientific article; zbMATH DE number 1505888 (Why is no real title available?)
- Clinical trials. A methodologic perspective
- Chain Graph Models and their Causal Interpretations
- Sample size re-estimation based on two-stage analysis of variance: Interim analysis of clinical trials
- Semiparametric Bayesian Survival Analysis using Models with Log‐linear Median
- Confidence interval for the difference between two median survival times with semiparametric transformation models
- Simulation of clinical trials: a review with emphasis on the design issues
- Evaluating clinical research. All that glitters is not gold
- Design and Analysis of Clinical Trials
- Proportional hazards models with random effects to examine centre effects in multicentre cancer clinical trials
- Introduction to statistical methods for clinical trials.
- Data monotoring in clinical trials. A case studies approach.
- Semiparametric Estimation of Proportional Mean Residual Life Model in Presence of Censoring
- Stratified Analysis in Randomized Trials with Noncompliance
- Global testing under sparse alternatives: ANOVA, multiple comparisons and the higher criticism
- Randomised trials with provision for early stopping for benefit (or harm): the impact on the estimated treatment effect
- Economic evaluation of factorial randomised controlled trials: challenges, methods and recommendations
- Quantifying the bias in the estimated treatment effect in randomized trials having interim analyses and a rule for early stopping for futility
- Accounting for competing risks in randomized controlled trials: a review and recommendations for improvement
- An empirical Bayes method for multivariate meta-analysis with an application in clinical trials
- Interval estimation of odds ratio in a stratified randomized clinical trial with noncompliance
- A class of mean residual life regression models with censored survival data
This page was built for publication: Clinical Trials
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5693362)